Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies

– Multi-target collaboration will leverage Antares’ proprietary discovery engine to generate highly selective small molecule medicines against historically undruggable oncology targets – – Antares to receive $105M upfront and is eligible for up to $1.8B in additional option exercise, development, regulatory, and commercial milestones, plus tiered royalties on global net sales – BOSTON, Mass. – […]